Effectiveness and durability of solifenacin versus percutaneous tibial nerve stimulation versus their combination for the treatment of women with overactive bladder syndrome: a randomized controlled study with a follow-up of ten months

Effectiveness and durability of solifenacin versus percutaneous tibial nerve stimulation versus their combination for the treatment of women with overactive bladder syndrome: a randomized controlled study with a follow-up of ten months

ABSTRACT Purpose To assess effectiveness and durability of Solifenacin (SS) versus tibial nerve stimulation (PTNS) versus combination therapy (PTNS + SS) in women with overactive bladder syndrome (OAB). Materials and Methods 105 women with OAB were divided randomly into three groups of 35 patients...

Full description

Bibliographic Details
Main Authors:	Carlo Vecchioli-Scaldazza, Carolina Morosetti
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Urologia
Series:	International Brazilian Journal of Urology
Subjects:	Urinary Bladder Overactive Combined Modality Therapy Solifenacin Succinate
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382018000100102&lng=en&tlng=en

Similar Items

Persistence and adherence of solifenacin treatment for Japanese women with overactive bladder
by: Minoru Kobayashi, et al.
Published: (2012-10-01)

Solifenacin versus posterior tibial nerve stimulation for overactive bladder in patients with multiple sclerosis
by: Nastaran Majdinasab, et al.
Published: (2023-02-01)

Solifenacin in overactive bladder syndrome: pharmacoeconomic analysis
by: Sergio Iannazzo, et al.
Published: (2008-03-01)

Solifenacin and Tolterodine are Equally Effective in the Treatment of Overactive Bladder Symptoms
by: Chen-Hsun Ho, et al.
Published: (2010-10-01)

Effect of electroacupuncture versus solifenacin for moderate and severe overactive bladder: a multi-centre, randomized controlled trial study protocol
by: Qian Wen, et al.
Published: (2020-07-01)

A randomized, multicenter, controlled study, comparing efficacy and safety of a new complementary and alternative medicine (CAM) versus Solifenacin Succinate in women with overactive bladder syndrome
by: Carlo Vecchioli-Scaldazza, et al.
Published: (2017-12-01)

THE EFFICACY COMPARISON OF MIRABEGRON AS A MONOTHERAPY VERSUS ITS COMBINATION WITH SOLIFENACIN IN OVERACTIVE BLADDER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
by: Hasan Madani, et al.
Published: (2021-07-01)

Predictors of non-persistence in women with overactive bladder syndrome
by: Sheng-Mou Hsiao
Published: (2024-03-01)

Regular and Irregular Use and Reasons for Discontinuation of Solifenacin Therapy in Patients with Overactive Bladder Managed by Urologists
by: Mateusz Małkowski, et al.
Published: (2024-01-01)

Transcutaneous tibial neurostimulation and Solifenacin in urgent incontinence of postmenopausal women
by: Hojjat Radinmehr, et al.
Published: (2023-06-01)

Percutaneous tibial nerve stimulation versus electrical stimulation with pelvic floor muscle training for overactive bladder syndrome in women: results of a randomized controlled study
by: Carlo Vecchioli Scaldazza, et al.

Efficacy and tolerability of mirabegron in female patients with overactive bladder symptoms after surgical treatment for stress urinary incontinence
by: Mete Özkidik, et al.

A rare case report of levofloxacin- and solifenacin-induced acute anaphylactic reaction in an elderly patient
by: Satish Eknath Bahekar, et al.
Published: (2019-01-01)

Pooled solifenacin overactive bladder trial data: Creation, validation and analysis of an integrated database
by: Christopher R. Chapple, et al.
Published: (2016-12-01)

Treating overactive bladder symptoms after transurethral prostatic surgery for benign prostatic hyperplasia – Which medication to choose?
by: Cheng-Ling Lee, et al.
Published: (2023-01-01)

Weak association between arterial hypertension and overactive bladder baseline symptoms and treatment responses
by: Martin C. Michel, et al.
Published: (2022-12-01)

Assessment of Anticholinergic Use After Fading of BTX-A Effects in Refractory Idiopathic Overactive Bladder: A Prospective Blinded Randomized Trial
by: M.A. Elbaset, et al.
Published: (2019-09-01)

Clinical Efficacy of Solifenacin in the Management of Diabetes Mellitus-Associated Versus Idiopathic Overactive Bladder Symptoms: A Multicenter Prospective Study
by: Hoon Choi, et al.
Published: (2018-03-01)

Efficacy and tolerability of mirabegron compared with solifenacin for children with idiopathic overactive bladder: A preliminary study
by: Seong Cheol Kim, et al.
Published: (2021-05-01)

Effectiveness of percutaneous tibial nerve stimulation in the treatment of overactive bladder syndrome
by: de Wall LL, et al.
Published: (2017-08-01)

The relation between the storage symptoms before and after transurethral resection of the prostate, analysis of the risk factors and the prevention of the symptoms with solifenacin
by: Timucin Sipal, et al.

Efficacy of Additional Solifenacin Succinate Therapy for Storage Symptoms in Females with Uncomplicated Lower Urinary Tract Infection: The SOLUTION Randomized Controlled Trial
by: Harrina Erlianti Rahardjo, et al.
Published: (2018-10-01)

OVERACTIVE BLADDER IN WOMEN WITH GENITAL PROLAPSE DURING MENOPAUSE
by: A. G. Imelbayeva, et al.
Published: (2017-12-01)

Metabolomics approach: Interpretation of changes in rat plasma metabolites after solifenacin treatment
by: Tugrul Cagri Akman, et al.
Published: (2022-11-01)

Percutaneous Tibial Nerve Stimulation in the Treatment of Refractory Idiopathic Overactive Bladder Syndrome: A Retrospective Cohort Study
by: Janine Nicole Frey, et al.
Published: (2023-10-01)

Vinpocetine Ameliorates Metabolic-Syndrome-Associated Bladder Overactivity in Fructose-Fed Rats by Restoring Succinate-Modulated cAMP Levels and Exerting Anti-Inflammatory Effects in the Bladder Detrusor Muscle
by: Wei-Chia Lee, et al.
Published: (2022-10-01)

Role of percutaneous tibial nerve stimulation in the management of the detrusor overactivity
by: Emad K El Tair, et al.
Published: (2022-01-01)

Percutaneous posterior tibial nerve stimulation for the treatment of the overactive bladder in children: Is it effective?
by: Hisham Ibrahim, et al.
Published: (2019-11-01)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
by: Mohammed A. Al-Ghazo, et al.
Published: (2011-03-01)

Novel Bioequivalent Tablet of Solifenacin Succinate Prepared Using Direct Compression Technique for Improved Chemical Stability
by: Do Hwan Kim, et al.
Published: (2023-06-01)

Botulinum toxin A for the Treatment of Overactive Bladder
by: Po-Fan Hsieh, et al.
Published: (2016-02-01)

The Urobiome and Its Role in Overactive Bladder
by: Sangrak Bae, et al.
Published: (2022-09-01)

ONABOTULINUM TOXIN-A FOR OVERACTIVE BLADDER
by: Mahmood Shakir Abdulkarim
Published: (2016-12-01)

Clustering of patients with overactive bladder syndrome
by: James Gross, et al.
Published: (2021-03-01)

Overactive bladder
by: Anna Zwierzyńska
Published: (2021-07-01)

Long-Term Effects of Percutaneous Tibial Nerve Stimulation Treatment for Neurogenic Overactive Bladder Due to Multiple Sclerosis: 24-Month Results
by: Mehmet Sevim, et al.
Published: (2023-01-01)

Effect of caffeine on bladder function in patients with overactive bladder symptoms
by: Supatra Lohsiriwat, et al.
Published: (2011-01-01)

Mediterranean Diet and Overactive Bladder
by: Yunus Erol Bozkurt, et al.
Published: (2022-06-01)

Development of an Improved Animal Model of Overactive Bladder: Transperineal Ligation versus Transperitoneal Ligation in Male Rats
by: Woo Hyun Kim, et al.
Published: (2016-08-01)

Cerebellar Ataxia and Overactive Bladder after Encephalitis Affecting the Cerebellum
by: Megumi Sugiyama, et al.
Published: (2009-07-01)